Removing large wine measures cuts drinking by 7.6% in study
With the largest measure off the menu, 7.6% less volume of wine was sold daily, researchers found.
Similar Posts
England's sexual health services 'at breaking point'
Soaring rates of gonorrhoea and syphilis infections threaten to overwhelm services, experts warn.
Hughie and Freddie: Fundraising teen on moment he got cancer all-clear
A 13-year-old boy who has raised thousands for charity after being diagnosed with leukaemia has shared his delight at being given the all clear. In a tearful video, Hughie thanked his best friend Freddie, who played a big part in his fundraising. Watch as they tell BBC Breakfast about the moment they got the good…
Depression could be ‘zapped’ away with brain stimulation, new study suggests: ‘Better quality of life’
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Catherine, Princess of Wales, leaves hospital after surgery
The Princess of Wales leaves hospital almost two weeks after having abdominal surgery.
Moderna Covid vaccine sales plunge in 2023, but meet company forecast
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer people rolled up their sleeves for an updated version of the jab. The revenue from the shots met Moderna’s forecast for the year, even as sales plummeted from the…
These 4 anti-obesity drug stocks could soar, Berenberg says
The anti-obesity drug market is expected to remain in focus this year after a bumper 2023 for weight loss drugmakers Novo Nordisk and Eli Lilly , according to Berenberg. The Germany-headquartered investment bank expects a combination of new clinical data, and the expiry of Novo ‘s patent for the active ingredient in first-generation GLP-1 drugs,…